tRF-003634 alleviates adriamycin-induced podocyte injury by reducing the stability of TLR4 mRNA.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
07
2023
accepted:
03
10
2023
medline:
23
10
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
epublish
Résumé
Podocyte injury plays a key role in the production of proteinuria and is closely related to the progression of chronic kidney disease (CKD). Alleviating podocyte injury is beneficial to prevent the occurrence and development of CKD. tRNA-derived RNA fragments (tRFs) are associated with podocytes injury processes such as protein binding, cell adhesion, synapses, the actin cytoskeleton. Our previous data showed that tRF-003634 tightly correlated with podocyte injury, while its effect remains unclear. This study aimed to investigate the role of tRF-003634 in podocyte injury and the potential mechanisms. The expression level of tRF-003634, nephrin, podocin and tRF-003634 targeted toll-like receptor 4 (TLR4) in podocytes and kidney tissues were examined by quantitative real-time PCR (qRT-PCR), western blot and immunohistochemistry. The biochemical indices were monitored and renal pathological changes were assessed by hematoxylin and eosin PAS staining. Furthermore, potential target genes of tRF-003634 were screened using high-throughput mRNA sequencing, and then confirmed by RNA pulse-chase analysis. The results showed that tRF-003634 was downregulated in adriamycin (Adr)-induced podocyte injury. Overexpression of tRF-003634 increased the expression of nephrin and podocin in vivo and in vitro and alleviated podocyte injury. Meanwhile, overexpression of tRF-003634 alleviated proteinuria and renal pathological damage. In addition, high-throughput sequencing after overexpression of tRF-003634 showed that TLR4 might be a downstream target gene. tRF-003634 can alleviate podocyte injury by reducing the stability of TLR4 mRNA, possibly by competing with TLR4 mRNA to bind to YTH domain-containing protein 1 (YTHDC1). In conclusion, tRF-003634 was underexpressed in Adr-induced podocyte injury, and its overexpression alleviated podocyte injury in vitro and in vivo by reducing the stability of TLR4 mRNA.
Identifiants
pubmed: 37856510
doi: 10.1371/journal.pone.0293043
pii: PONE-D-23-23718
pmc: PMC10586663
doi:
Substances chimiques
Doxorubicin
80168379AG
RNA, Messenger
0
TLR4 protein, human
0
Toll-Like Receptor 4
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0293043Informations de copyright
Copyright: © 2023 Gao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cell. 2015 May 7;161(4):790-802
pubmed: 25957686
Trends Genet. 2020 Mar;36(3):177-188
pubmed: 31964509
Biochem Biophys Res Commun. 2020 Jan 1;521(1):1-8
pubmed: 31629473
Nephrology (Carlton). 2011 Jan;16(1):30-8
pubmed: 21175974
Genomics Proteomics Bioinformatics. 2018 Apr;16(2):99-107
pubmed: 29715522
Biomed Res Int. 2020 Jun 22;2020:7826763
pubmed: 32685525
J Mol Med (Berl). 2018 Nov;96(11):1167-1176
pubmed: 30232504
Cell Mol Life Sci. 2021 Oct;78(19-20):6721-6734
pubmed: 34568976
Nucleic Acids Res. 2020 Sep 25;48(17):9433-9448
pubmed: 32890397
RNA Biol. 2021 Dec;18(12):2157-2167
pubmed: 33998370
J Autoimmun. 2010 Dec;35(4):358-67
pubmed: 20833510
J Nephrol. 2017 Dec;30(6):719-727
pubmed: 28933050
Am J Kidney Dis. 2018 Nov;72(5):628-630
pubmed: 30343730
Cell Mol Life Sci. 2021 Mar;78(6):2607-2619
pubmed: 33388834
Mol Cell. 2016 Feb 18;61(4):507-519
pubmed: 26876937
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Cancer Lett. 2018 Apr 10;419:1-7
pubmed: 29337107
Int Immunopharmacol. 2018 Jun;59:391-412
pubmed: 29730580
Am J Nephrol. 2015;41(4-5):277-83
pubmed: 26021523
Int J Mol Sci. 2020 Sep 13;21(18):
pubmed: 32933213
J Am Soc Nephrol. 2015 Feb;26(2):258-69
pubmed: 25060060
Kidney Dis (Basel). 2021 Jan;7(1):14-23
pubmed: 33614730
Annu Rev Physiol. 2018 Feb 10;80:309-326
pubmed: 29068765
J Endocr Soc. 2020 Mar 05;4(4):bvaa029
pubmed: 32232184
RNA. 2021 Apr;27(4):477-495
pubmed: 33446492
Gene. 2016 Apr 1;579(2):133-8
pubmed: 26743126
Cancers (Basel). 2019 Aug 23;11(9):
pubmed: 31450747
JAMA. 2019 Oct 1;322(13):1294-1304
pubmed: 31573641
J Am Soc Nephrol. 2008 Apr;19(4):704-13
pubmed: 18256364
Nephrol Dial Transplant. 2016 Oct;31(10):1577-83
pubmed: 26968197
RNA. 2017 Feb;23(2):142-152
pubmed: 27872161
Nat Rev Nephrol. 2021 Mar;17(3):185-204
pubmed: 32943753
RNA Biol. 2016 Sep;13(9):756-9
pubmed: 27351695